UZ Leuven

Gastroenterology and Inflammatory Bowel Disease

Research activity includes Crohn’s disease, acute severe ulcerative colitis, pouchitis, short bowel syndrome, irritable bowel syndrome, functional dyspepsia, gastro-oesophageal reflux disease, and opioid-induced constipation.

  • Inflammatory bowel disease surgery and recurrence
  • Intestinal motility and upper gastrointestinal symptoms
  • Supportive care in gastrointestinal disorders

Additional work spans infliximab treatment strategies, proton pump inhibitor deprescribing, and symptom-focused care in chronic digestive disease.

Oncology and Hematologic Malignancy

The oncology portfolio covers gastro-esophageal adenocarcinoma, pancreatic ductal adenocarcinoma, colorectal cancer, rectal cancer, breast cancer, prostate cancer, ovarian cancer, and malignant melanoma.

  • Targeted treatment in receptor-defined cancers
  • Metastasis-directed approaches in advanced solid tumors
  • Perioperative and neoadjuvant cancer care

Studies also address febrile neutropenia, tumor imaging with PET/CT, and treatment selection in clinically challenging oncologic settings.

Neurology, Neurodegeneration, and Developmental Disorders

Clinical research includes Alzheimer disease, frontotemporal dementia, Lewy body disease, Parkinson’s disease, multiple system atrophy, amyotrophic lateral sclerosis, spinal muscular atrophy, autism spectrum disorder, cerebral palsy, traumatic brain injury, and drug-resistant epilepsy.

  • Neurodegenerative disease characterization
  • Motor and cognitive outcome assessment
  • Pediatric neurodevelopmental care

Imaging and biomarker work extends to tau pathology, carotid atherosclerosis, and functional brain circuit studies.

Rheumatology, Dermatology, and Immune-Mediated Disease

Studies focus on rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, giant cell arteritis, IgG4-related disease, hidradenitis suppurativa, chronic rhinosinusitis with nasal polyps, and nonsteroidal anti-inflammatory drug-exacerbated respiratory disease.

  • Biologic and targeted immune therapy
  • Vasculitis and inflammatory airway disease
  • Inflammatory skin and joint disorders

Research also addresses dupilumab, rituximab, tofacitinib, and anti-TNF strategies in immune-mediated conditions.

Perioperative Care, Critical Care, and Clinical Pharmacology

Trials span infective endocarditis, severe community-acquired pneumonia, prosthetic joint infections, fracture-related infections, cardiac surgery, obstetric and fetal surgery, and intensive care management in critically ill patients.

  • Antimicrobial treatment optimization
  • Perioperative analgesia and anesthesia
  • Drug exposure and pharmacokinetics in complex care

Additional interests include ceftazidime-avibactam, clindamycin, apixaban, ketamine, oxytocin, and naloxegol.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study of Switching from Intravenous to Oral Antibiotics in Patients with Infective Endocarditis Using a Drug Combination

    Recruiting

    3 1 1 1
    Investigated diseases:
    Belgium
  • A Study Using [AL[18F]F]FAPI-74 PET Scan to Improve Diagnosis and Monitoring of Giant Cell Arteritis in Patients with This Blood Vessel Disease

    Recruiting

    4 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium
  • Study of Ropivacaine for Pain Control in Patients Having Open Heart Surgery Through Chest Bone Incision

    Recruiting

    3 1 1
    Belgium
  • Study of Zolbetuximab combined with Paclitaxel and Ramucirumab for patients with previously treated CLDN18.

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium
  • Study of guselkumab and dietary changes for patients with recurring or difficult-to-treat pouchitis

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium